Table. 8.

Number (%) of participants in the proficiency tests for the direct antiglobulin test

TrialAntiglobulinSpecimenNumberResult Intended response

PositiveNegative
1stPolyspecificBBG-17-04253253 (100.0)   Negative
BBG-17-05253 (100.0)   Negative
BBG-17-06253 (100.0)0   Positive
Anti-IgGBBG-17-0467067 (100.0)   Negative
BBG-17-05067 (100.0)   Negative
BBG-17-0667 (100.0)0   Positive
Anti-C3dBBG-17-0473073 (100.0)   Negative
BBG-17-05073 (100.0)   Negative
BBG-17-0612 (16.4)*61 (83.6)   Negative
2ndPolyspecificBBG-17-10258258 (100.0)   Negative
BBG-17-112 (0.8)*256 (99.2)   Negative
BBG-17-12257 (99.6)1 (0.4)*   Positive
Anti-IgGBBG-17-106868 (100.0)   Negative
BBG-17-1168 (100.0)   Negative
BBG-17-1268 (100.0)   Positive
Anti-C3dBBG-17-107171 (100.0)   Negative
BBG-17-1171 (100.0)   Negative
BBG-17-129 (12.7)*62 (87.3)   Negative

Values are presented as number (%), unless otherwise stated

Abbreviation: IgG, immunoglobulin G

Unacceptable responses for direct antiglobulin test

J Lab Med Qual Assur 2018;40:9~20 https://doi.org/10.15263/jlmqa.2018.40.1.9
© Lab Med Qual Assur